Wei (Michelle) Zhang
About Wei (Michelle) Zhang
Wei (Michelle) Zhang serves as the Vice President and Head of Biometrics at AffaMed Therapeutics, a position she has held since 2021. She has extensive experience in statistical analysis, having previously worked at the FDA for over a decade and held leadership roles in various organizations.
Current Role at AffaMed Therapeutics
Wei (Michelle) Zhang currently serves as the Vice President and Head of Biometrics at AffaMed Therapeutics. She has held this position since 2021, contributing her expertise in biometrics within the pharmaceutical industry. Her role involves overseeing statistical methodologies and data analysis to support clinical development and regulatory submissions.
Previous Experience at FDA
Zhang worked at the FDA for a total of 11 years, where she held two significant positions. From 2009 to 2017, she served as a Mathematical Statistician, followed by a promotion to Supervisory Mathematical Statistician from 2017 to 2020. In these roles, she was responsible for statistical analysis and guidance on regulatory matters, enhancing her experience in the field of biostatistics.
Experience at PPC佳生
Before joining AffaMed Therapeutics, Zhang was the Senior Director and Head of US operations at PPC佳生 from 2020 to 2021. In this role, she managed biometrics and statistical functions, contributing to the company's strategic initiatives in the United States.
Education and Expertise
Zhang holds a Bachelor's degree from the University of Science and Technology of China. She further advanced her education by earning a Doctor of Philosophy (PhD) in Statistics from the University of Pittsburgh. Her academic background provides a strong foundation for her work in biometrics and statistical analysis in the pharmaceutical sector.